Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107415664> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2107415664 endingPage "219" @default.
- W2107415664 startingPage "215" @default.
- W2107415664 abstract "This trial was designed to determine the 1-year survival rate, efficacy, and safety, produced by topotecan and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (ANSCLC). Fifty-three patients were enrolled; 51 received treatment. Topotecan 1 mg/m(2), days 1-5 and gemcitabine 1 g/m(2) days 1 and 15 were administered IV, each drug over 30 min; cycles consisted of 28 days. Treatment continued until progressive disease or intolerable toxicity. Nineteen patients (36%) had Eastern Cooperative Oncology Group criteria performance status (ECOG PS) = 0, 34 (64%) PS = 1. Median age was 64 years; 37 patients (70%) were male.adenocarcinoma (42%), squamous cell carcinoma (28%), large cell (19%), and unclassified (11%). Among 47 evaluable patients, eight (17%) had partial response, 11 (23%) had stable disease. One-year survival was 39% and median survival was 7.6 months (range, < 1-19.6). Grade 3 and 4 toxicities included neutropenia (53%), anemia (18%), thrombocytopenia (12%), asthenia (8%), and gastrointestinal disorders (8%); three patients (6%) experienced neutropenic fever. There were no treatment-related deaths. The combination topotecan/gemcitabine produced a 1-year survival similar to previous platinum-based regimens, when used as first line chemotherapy for ANSCLC. The toxicity profile was acceptable." @default.
- W2107415664 created "2016-06-24" @default.
- W2107415664 creator A5022470842 @default.
- W2107415664 creator A5025701159 @default.
- W2107415664 creator A5028916394 @default.
- W2107415664 creator A5055054082 @default.
- W2107415664 creator A5065675425 @default.
- W2107415664 creator A5068316683 @default.
- W2107415664 creator A5080407335 @default.
- W2107415664 date "2003-02-01" @default.
- W2107415664 modified "2023-10-18" @default.
- W2107415664 title "A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer" @default.
- W2107415664 cites W1483985834 @default.
- W2107415664 cites W1857624176 @default.
- W2107415664 cites W1858072261 @default.
- W2107415664 cites W1979300931 @default.
- W2107415664 cites W1992937413 @default.
- W2107415664 cites W2014725195 @default.
- W2107415664 cites W2020331694 @default.
- W2107415664 cites W2070962078 @default.
- W2107415664 cites W2082928681 @default.
- W2107415664 cites W2083747715 @default.
- W2107415664 cites W2128746268 @default.
- W2107415664 cites W2129793148 @default.
- W2107415664 cites W2504684570 @default.
- W2107415664 cites W6195560 @default.
- W2107415664 doi "https://doi.org/10.1016/s0169-5002(02)00502-0" @default.
- W2107415664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12581576" @default.
- W2107415664 hasPublicationYear "2003" @default.
- W2107415664 type Work @default.
- W2107415664 sameAs 2107415664 @default.
- W2107415664 citedByCount "15" @default.
- W2107415664 countsByYear W21074156642015 @default.
- W2107415664 countsByYear W21074156642017 @default.
- W2107415664 countsByYear W21074156642022 @default.
- W2107415664 crossrefType "journal-article" @default.
- W2107415664 hasAuthorship W2107415664A5022470842 @default.
- W2107415664 hasAuthorship W2107415664A5025701159 @default.
- W2107415664 hasAuthorship W2107415664A5028916394 @default.
- W2107415664 hasAuthorship W2107415664A5055054082 @default.
- W2107415664 hasAuthorship W2107415664A5065675425 @default.
- W2107415664 hasAuthorship W2107415664A5068316683 @default.
- W2107415664 hasAuthorship W2107415664A5080407335 @default.
- W2107415664 hasConcept C126322002 @default.
- W2107415664 hasConcept C141071460 @default.
- W2107415664 hasConcept C143998085 @default.
- W2107415664 hasConcept C2776256026 @default.
- W2107415664 hasConcept C2776694085 @default.
- W2107415664 hasConcept C2776907518 @default.
- W2107415664 hasConcept C2777063308 @default.
- W2107415664 hasConcept C2778248108 @default.
- W2107415664 hasConcept C2778850193 @default.
- W2107415664 hasConcept C2780258809 @default.
- W2107415664 hasConcept C2781209748 @default.
- W2107415664 hasConcept C31760486 @default.
- W2107415664 hasConcept C71924100 @default.
- W2107415664 hasConcept C90924648 @default.
- W2107415664 hasConceptScore W2107415664C126322002 @default.
- W2107415664 hasConceptScore W2107415664C141071460 @default.
- W2107415664 hasConceptScore W2107415664C143998085 @default.
- W2107415664 hasConceptScore W2107415664C2776256026 @default.
- W2107415664 hasConceptScore W2107415664C2776694085 @default.
- W2107415664 hasConceptScore W2107415664C2776907518 @default.
- W2107415664 hasConceptScore W2107415664C2777063308 @default.
- W2107415664 hasConceptScore W2107415664C2778248108 @default.
- W2107415664 hasConceptScore W2107415664C2778850193 @default.
- W2107415664 hasConceptScore W2107415664C2780258809 @default.
- W2107415664 hasConceptScore W2107415664C2781209748 @default.
- W2107415664 hasConceptScore W2107415664C31760486 @default.
- W2107415664 hasConceptScore W2107415664C71924100 @default.
- W2107415664 hasConceptScore W2107415664C90924648 @default.
- W2107415664 hasIssue "2" @default.
- W2107415664 hasLocation W21074156641 @default.
- W2107415664 hasLocation W21074156642 @default.
- W2107415664 hasOpenAccess W2107415664 @default.
- W2107415664 hasPrimaryLocation W21074156641 @default.
- W2107415664 hasRelatedWork W1990777236 @default.
- W2107415664 hasRelatedWork W2063374291 @default.
- W2107415664 hasRelatedWork W2072029106 @default.
- W2107415664 hasRelatedWork W2107415664 @default.
- W2107415664 hasRelatedWork W2138837920 @default.
- W2107415664 hasRelatedWork W2160583837 @default.
- W2107415664 hasRelatedWork W2519824048 @default.
- W2107415664 hasRelatedWork W2598870424 @default.
- W2107415664 hasRelatedWork W2945540985 @default.
- W2107415664 hasRelatedWork W4247775848 @default.
- W2107415664 hasVolume "39" @default.
- W2107415664 isParatext "false" @default.
- W2107415664 isRetracted "false" @default.
- W2107415664 magId "2107415664" @default.
- W2107415664 workType "article" @default.